Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument
- 1 January 2022
- journal article
- research article
- Published by COPD Foundation in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
- Vol. 9 (2) , 195-208
Abstract
Rationale: It has been suggested that patients with chronic obstructive pulmonary disease (COPD) experience considerable daily respiratory symptom fluctuation. A standardized measure is needed to quantify and understand the implications of day-to-day symptom variability. Objectives: To compare standard deviation with other statistical measures of symptom variability and identify characteristics of individuals with higher symptom variability. Methods: Individuals in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) Exacerbations sub-study completed an Evaluating Respiratory Symptoms in COPD (E-RS) daily questionnaire. We calculated within-subject standard deviation (WS-SD) for each patient at week 0 and correlated this with measurements obtained 4 weeks later using Pearson's r and Bland Altman plots. Median WS-SD value dichotomized participants into higher versus lower variability groups. Association between WS-SD and exacerbation risk during 4 follow-up weeks was explored. Measurements and Main Results: Diary completion rates were sufficient in 140 (68%) of 205 sub-study participants. Reproducibility (r) of the WS-SD metric from baseline to week 4 was 0.32. Higher variability participants had higher St George's Respiratory Questionnaire (SGRQ) scores (47.3 +/- 20.3 versus 39.6 +/- 21.5, p=.04) than lower variability participants. Exploratory analyses found no relationship between symptom variability and health care resource utilization-defined exacerbations. Conclusions: WS-SD of the E-RS can be used as a measure of symptom variability in studies of patients with COPD. Patients with higher variability have worse health-related quality of life. WS-SD should be further validated as a measure to understand the implications of symptom variability.Keywords
This publication has 24 references indexed in Scilit:
- Performance of the EXAcerbations of Chronic Pulmonary Disease Tool Patient-reported Outcome Measure in Three Clinical Trials of Chronic Obstructive Pulmonary DiseaseAnnals of the American Thoracic Society, 2014
- The impact of morning symptoms on daily activities in chronic obstructive pulmonary diseaseCurrent Medical Research and Opinion, 2013
- Impact of night-time symptoms in COPD: a real-world study in five European countriesInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1Thorax, 2013
- Real World COPD: Association of Morning Symptoms with Clinical and Patient Reported OutcomesCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2013
- Variabilidad de los síntomas respiratorios en la EPOC graveArchivos de Bronconeumología, 2012
- Patient's Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL StudyThe Korean Journal of Internal Medicine, 2012
- Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations: Reliability and Validity of a Patient-reported DiaryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Symptom variability in patients with severe COPD: a pan-European cross-sectional studyEuropean Respiratory Journal, 2010
- Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurrent Medical Research and Opinion, 2009